ABL BIOTEC A/S: Financial statements 2012
CVR: 50811018
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -50,503 and a net result of DKK 3,685,841. Equity in the 2012 report amounted to DKK 21,513,448. The solvency ratio was 99.8%.
- Gross Profit
- DKK -50,503
- Profit/Loss
- DKK 3,685,841
- Equity
- DKK 21,513,448
- Total Assets
- DKK 21,550,630
Official annual report
Keep an eye on ABL BIOTEC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, MJAKP2 I/S has stepped down as auditor of ABL BIOTEC A/S.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.